Related Experiment Video
Updated: Nov 4, 2025
11:51
Combining Behavioral Endocrinology and Experimental Economics: Testosterone and Social Decision Making
Published on: March 2, 2011
15.3K
[Practical recommendations for the management of testosterone deficiency]
Summary
French experts developed new guidelines for managing testosterone deficiency (TD). Diagnosis requires low testosterone levels and symptoms, with treatment focusing on supplementation and lifestyle changes.
Area of Science:
- Andrology
- Sexual Medicine
- Endocrinology
Background:
- Testosterone deficiency (TD) is characterized by clinical signs and symptoms alongside reduced testosterone levels.
- Diagnosis requires two successive low testosterone assays in young men.
- Sexual dysfunction, fatigue, and mood changes are common manifestations.
Purpose of the Study:
- To establish French clinical practice recommendations for managing testosterone deficiency (TD).
- To provide expert guidance on diagnosis and treatment of TD.
Main Methods:
- Systematic literature review from 2000 to 2019.
- Utilized the AGREE II grid for recommendation quality assessment.
- Panel of experts from SFMS and AFU-CAMS developed guidelines.
Main Results:
- TD diagnosis involves clinical symptoms and confirmed low testosterone (T).
- Free or bioavailable T is preferred over total T due to frequent SHBG abnormalities.
- Treatment requires clinical and biological assessment, with contraindications and specific patient groups identified.
Conclusions:
- These recommendations aim to enhance the clinical management of testosterone deficiency.
- Improved diagnostic and therapeutic strategies for TD are proposed.
Related Concept Videos
01:26Testosterone: Functions and Regulation
1.4K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.4K
01:20Disorders of the Male Reproductive System
3.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.2K
01:23Infertility in Males
378
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
378
01:26Atherosclerosis III: Management
89
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
01:29Therapeutic Drug Monitoring: Affecting Factors
49
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
49
01:28Menopause
2.9K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
2.9K